These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16859997

  • 1. MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: association with muscle involvement.
    O'Connor KA, Abbott KA, Sabin B, Kuroda M, Pachman LM.
    Clin Immunol; 2006 Sep; 120(3):319-25. PubMed ID: 16859997
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
    Soponkanaporn S, Deakin CT, Schutz PW, Marshall LR, Yasin SA, Johnson CM, Sag E, Tansley SL, McHugh NJ, Wedderburn LR, Jacques TS.
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis.
    Abramson LS, Albertini RJ, Pachman LM, Finette BA.
    Clin Immunol; 1999 Apr; 91(1):61-7. PubMed ID: 10219255
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis.
    Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, Bremer EG, Krasnoselska-Riz I, Kumar A, Pachman LM.
    J Immunol; 2002 Apr 15; 168(8):4154-63. PubMed ID: 11937576
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dermatomyositis in six patients without initial muscle involvement.
    Krain L.
    Arch Dermatol; 1975 Feb 15; 111(2):241-5. PubMed ID: 1078762
    [Abstract] [Full Text] [Related]

  • 11. Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
    Wienke J, Deakin CT, Wedderburn LR, van Wijk F, van Royen-Kerkhof A.
    Front Immunol; 2018 Feb 15; 9():2951. PubMed ID: 30619311
    [Abstract] [Full Text] [Related]

  • 12. Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.
    Shrestha S, Wershil B, Sarwark JF, Niewold TB, Philipp T, Pachman LM.
    Arthritis Rheum; 2010 Sep 15; 62(9):2813-22. PubMed ID: 20506305
    [Abstract] [Full Text] [Related]

  • 13. Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.
    Preuße C, Allenbach Y, Hoffmann O, Goebel HH, Pehl D, Radke J, Doeser A, Schneider U, Alten RH, Kallinich T, Benveniste O, von Moers A, Schoser B, Schara U, Stenzel W.
    Acta Neuropathol Commun; 2016 Apr 27; 4(1):45. PubMed ID: 27121733
    [Abstract] [Full Text] [Related]

  • 14. Elevated type I IFN signalling directly affects CD8+ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients.
    Huang B, Li H, Jiang Q, Li Y, Jiang Z, Cao H, Wang S, Wang X, Li J, Li G.
    J Autoimmun; 2024 Jun 27; 146():103232. PubMed ID: 38692172
    [Abstract] [Full Text] [Related]

  • 15. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    Clin Dev Immunol; 2006 Jun 27; 13(2-4):283-7. PubMed ID: 17162369
    [Abstract] [Full Text] [Related]

  • 16. Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis.
    Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, Tawil R, Barohn RJ, Saperstein DS, Briemberg HR, Ericsson M, Park P, Amato AA.
    Ann Neurol; 2005 May 27; 57(5):664-78. PubMed ID: 15852401
    [Abstract] [Full Text] [Related]

  • 17. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
    Musumeci G, Castrogiovanni P, Barbagallo I, Tibullo D, Sanfilippo C, Nunnari G, Pellicanò GF, Pavone P, Caltabiano R, Di Marco R, Imbesi R, Di Rosa M.
    Int J Mol Sci; 2018 Sep 17; 19(9):. PubMed ID: 30227596
    [Abstract] [Full Text] [Related]

  • 18. Prognosis in childhood dermatomyositis.
    Sullivan DB, Cassidy JT, Petty RE, Burt A.
    J Pediatr; 1972 Apr 17; 80(4):555-63. PubMed ID: 5015065
    [No Abstract] [Full Text] [Related]

  • 19. MHC Class I overexpression on muscles in early juvenile dermatomyositis.
    Li CK, Varsani H, Holton JL, Gao B, Woo P, Wedderburn LR, Juvenile Dermatomyositis Research Group (UK and Ireland).
    J Rheumatol; 2004 Mar 17; 31(3):605-9. PubMed ID: 14994413
    [Abstract] [Full Text] [Related]

  • 20. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
    Kim H, Gunter-Rahman F, McGrath JA, Lee E, de Jesus AA, Targoff IN, Huang Y, O'Hanlon TP, Tsai WL, Gadina M, Miller FW, Goldbach-Mansky R, Rider LG.
    Arthritis Res Ther; 2020 Apr 06; 22(1):69. PubMed ID: 32252809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.